featured
Nivolumab for Previously Treated Unresectable Metastatic Anal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nivolumab for Previously Treated Unresectable Metastatic Anal Cancer (NCI9673): A Multicentre, Single-Arm, Phase 2 Study
Lancet Oncol 2017 Feb 17;[EPub Ahead of Print], VK Morris, ME Salem, H Nimeiri, S Iqbal, P Singh, K Ciombor, B Polite, D Deming, E Chan, JL Wade, L Xiao, T Bekaii-Saab, L Vence, J Blando, A Mahvash, WC Foo, C Ohaji, M Pasia, G Bland, A Ohinata, J Rogers, A Mehdizadeh, K Banks, R Lanman, RA Wolff, H Streicher, J Allison, P Sharma, C EngFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.